[Federal Register Volume 76, Number 22 (Wednesday, February 2, 2011)]
[Notices]
[Pages 5814-5815]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-2261]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH or Advisory 
Board), National Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42 
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), 
announces the following meeting of the aforementioned committee:
    Board Public Meeting Times and Dates (All times are Eastern Time):
    8:15 a.m.-3:45 p.m., February 23, 2011.
    8:15 a.m.-5:00 p.m., February 24, 2011.
    8:15 a.m.-10:30 a.m., February 25, 2011
    Public Comment Times and Dates (All times are Eastern Time):
    6:30 p.m.-7:30 p.m.*, February 23, 2011.
    5:30 p.m.-7 p.m.*, February 24, 2011.
    * Please note that the public comment periods may end before the 
times indicated, following the last call for comments. Members of the 
public who wish to provide public comments should plan to attend public 
comment sessions at the start times listed.
    Place: Augusta Marriott Hotel and Suites, Two Tenth Street, 
Augusta, Georgia 30901; Phone: 800-868-5354; Fax: 404-377-1587. Audio 
Conference Call via FTS Conferencing. The USA toll-free dial-in number 
is 1-866-659-0537 with a pass code of 9933701.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 150 people.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program (EEOICP) Act of 
2000 to advise the President on a variety of policy and technical 
functions required to implement and effectively manage the new 
compensation program. Key functions of the Advisory Board include 
providing advice on the development of probability of causation 
guidelines which have been promulgated by the Department of Health and 
Human Services (HHS) as a final rule, advice on methods of dose 
reconstruction which have also been promulgated by HHS as a final rule, 
advice on the scientific validity and quality of dose estimation and 
reconstruction efforts being performed for purposes of the compensation 
program, and advice on petitions to add classes of workers to the 
Special Exposure Cohort (SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2011.
    Purpose: This Advisory Board is charged with (a) providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advise the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class.
    Matters To Be Discussed: The agenda for the Advisory Board meeting 
includes: NIOSH Program Update and Program Evaluation Update; 
Department of Labor (DOL) Program Update; Department of Energy (DOE) 
Program Update; Savannah River Site Work Group Update; NIOSH Savannah 
River Site Activities Update; Use of Co-worker Data; the Application of 
OTIB-70 for Residual Contamination Periods; SEC petitions for: Linde 
Ceramics Plant (Tonawanda, New York), Dow Chemical (Madison, Illinois), 
Chapman Valve (Indian Orchard, Massachusetts), Wah Chang (Albany, OR), 
Grand Junction Operations Office (Grand Junction, CO), Bliss and 
Laughlin Steel (Buffalo, NY), Feed Materials Production Center 
(Fernald, OH), Norton Company (Worcester, MA), and Vitro Manufacturing 
(Canonsburg, PA); SEC Petition Status Updates; Subcommittee and Work 
Group Reports; Board Work Sessions, and an Administrative Session.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may be 
submitted in accordance with the redaction policy provided below. Any 
written comments received will be provided at the meeting and should be 
submitted to the contact person below well in advance of the meeting.

[[Page 5815]]

    Policy on Redaction of Board Meeting Transcripts (Public Comment): 
(1) If a person making a comment gives his or her name, no attempt will 
be made to redact that name. (2) NIOSH will take reasonable steps to 
ensure that individuals making public comment are aware of the fact 
that their comments (including their name, if provided) will appear in 
a transcript of the meeting posted on a public website. Such reasonable 
steps include: (a) A statement read at the start of each public comment 
period stating that transcripts will be posted and names of speakers 
will not be redacted; (b) A printed copy of the statement mentioned in 
(a) above will be displayed on the table where individuals sign up to 
make public comments; (c) A statement such as outlined in (a) above 
will also appear with the agenda for a Board Meeting when it is posted 
on the NIOSH website; (d) A statement such as in (a) above will appear 
in the Federal Register Notice that announces Board and Subcommittee 
meetings. (3) If an individual in making a statement reveals personal 
information (e.g., medical information) about themselves that 
information will not usually be redacted. The NIOSH Freedom of 
Information Act (FOIA) coordinator will, however, review such 
revelations in accordance with the FOIA and the Federal Advisory 
Committee Act and if deemed appropriate, will redact such information. 
(4) All disclosures of information concerning third parties will be 
redacted. (5) If it comes to the attention of the DFO that an 
individual wishes to share information with the Board but objects to 
doing so in a public forum, the DFO will work with that individual, in 
accordance with the Federal Advisory Committee Act, to find a way that 
the Board can hear such comments.
    Contact Person for More Information: Theodore Katz, M.P.A., 
Executive Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta GA 
30333, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO, e-mail: 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

    Dated: January 26, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-2261 Filed 2-1-11; 8:45 am]
BILLING CODE 4163-18-P